Peer Review reports
From: Clinical development of phosphatidylinositol 3-kinase inhibitors for cancer treatment
| Original Submission | ||
|---|---|---|
| 20 Jul 2012 | Submitted | Original manuscript |
| Resubmission - Version 2 | ||
| Submitted | Manuscript version 2 | |
| Resubmission - Version 3 | ||
| Submitted | Manuscript version 3 | |
| Reviewed | Reviewer Report | |
| Reviewed | Reviewer Report | |
| Resubmission - Version 4 | ||
| Submitted | Manuscript version 4 | |
| Author responded | Author comments | |
| Resubmission - Version 5 | ||
| Submitted | Manuscript version 5 | |
| Author responded | Author comments | |
| Resubmission - Version 6 | ||
| Submitted | Manuscript version 6 | |
| Author responded | Author comments | |
| Resubmission - Version 7 | ||
| Submitted | Manuscript version 7 | |
| Reviewed | Reviewer Report | |
| Resubmission - Version 8 | ||
| Submitted | Manuscript version 8 | |
| Publishing | ||
| 11 Dec 2012 | Editorially accepted | |
| 11 Dec 2012 | Article published | 10.1186/1741-7015-10-161 |
You can find further information about peer review here.